(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: HEALTHCARE: Former microbiologist Darnisha Grant Harrison, CEO of Ennaid Therapeutics, on developing a technology that shows 99% effectiveness against the Zika virus, and the company's plans to be the first-to-market with a cure.

Dick’s Falls Most Ever With Chairman Saying More Pain to Come
23:49

Alibaba Raises $10 Billion in Record Hong Kong Share Sale
24:42

Broadcom Seeks More Than $60 Billion in Latest AI Debt Deal
23:07